Can therapy be tailored to the person? a study seeks answers
NCT ID NCT04106713
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study looks at how people with depression or anxiety respond to different types of psychotherapy—individual sessions or an online program. It aims to find clues that predict who benefits most from each approach. By understanding these factors, doctors may better match patients to the right therapy, improving outcomes and making care more personal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Individual psychotherapy and internet-delivered cognitive behavioural therapy (iCBT)
- What this could lead to
- If successful, this could help match patients to the most effective therapy format, improving personalized mental health care.
- What could go wrong
- The study is observational and exploratory, so it may not identify clear predictors. Results may not apply beyond this hospital setting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Mental Health, Singapore
RECRUITINGSingapore, Singapore, 539747, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Middle school jitters: a new program aims to smooth the transition for anxious students
- Could a new drug offer hope for Treatment-Resistant depression?